The Impact of Obesity on Oxygen Desaturation during Sleep-disordered Breathing by Peppard, PE et al.
  
The impact of obesity on oxygen desaturation during sleep-disordered breathing 
 
*Paul E. Peppard1, Neil Ward2, Mary J Morrell2 
 
1. Department of Population Health Sciences, University of Wisconsin-Madison, 
WARF Building, #685, 610 Walnut St. Madison, WI 53726 
2. Clinical and Academic Unit of Sleep and Breathing, National Heart and Lung 
Institute, Imperial College London, Royal Brompton Hospital, Sydney Street, 
London, SW3 6NP, United Kingdom 
 
* Corresponding author, and address to which requests for reprints should be sent: 
Department of Population Health Sciences 
University of Wisconsin-Madison 
WARF Building, #685 
610 Walnut St. 
Madison, WI 53726 
608-262-2680 (voice), 608-263-8828 (fax), ppeppard@wisc.edu 
 
Supported by: NIH grants R01HL62252, R01AG14124, RR03186 and 1UL1RR025011; 
NW was funded by the British Heart Foundation and MJM by the Wellcome Trust. 
 
Running Title: BMI, O2 Desaturation & Sleep Apnea 
 
Descriptor: Sleep-disordered breathing: pathophysiology 
 1
 
Word Count: 3,154 
 
At a Glance Commentary: 
 
Scientific Knowledge on the Subject: Obesity increases the risk of sleep-
disordered breathing, but the extent to which excess body weight influences the 
amount of blood oxygen desaturation during apneic and hypopneic events has 
not been characterized.  
 
What This Study Adds to the Field: Mixed effects regression analysis of over 
37,000 breathing events, occurring in 750 participants of the Wisconsin Cohort 
Study, has shown that body mass index is a significant independent predictor of 
the amount of oxygen desaturation during apneas and hypopneas. Thus the 
impact of sleep disordered breathing may be greater in obesity due to 
exacerbation of intermittent hypoxia.  
 
This article has an online data supplement, which is accessible from this issue's table of 
content online at www.atsjournals.org 
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ABSTRACT 
Rationale: Obesity increases the risk and severity of sleep-disordered breathing. The 
degree to which excess body weight contributes to blood oxygen desaturation during 
hypopneic and apneic events has not been comprehensively characterized. 
Objectives: To quantify the association between excess body weight and oxygen 
desaturation during sleep-disordered breathing. 
Methods: 750 adult participants in the Wisconsin Sleep Cohort Study were assessed for 
body mass index (kg/m2) and sleep-disordered breathing. The amount of blood oxygen 
desaturation, duration and other characteristics of 37,473 observed breathing events 
were measured during polysomnography studies. A mixed-effects linear regression 
model estimated the association of blood oxygen desaturation with participant-level 
characteristics including body mass index, gender and age; and event-level 
characteristics including baseline blood oxygen saturation, change in tidal volume, event 
duration, sleep state, and body position. 
Measurements and Main Results: Body mass index was positively associated with 
oxygen desaturation severity, independent of age, gender, sleeping position, baseline 
blood oxygen saturation and event duration. Additionally, body mass index interacted 
with sleep state such that body mass index predicted greater desaturation in rapid eye 
movement (REM) sleep than in non-REM sleep. Each increment of 10 kg/m2 body mass 
index predicted a 1.0% (SE=0.2%) greater mean blood oxygen desaturation for persons 
in REM sleep experiencing hypopnea events associated with 80% tidal volume 
reductions. 
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Conclusions: Excess body weight is an important predictor of the severity of blood 
oxygen desaturation during apnea and hypopnea events, potentially exacerbating the 
impact of sleep-disordered breathing in obese patients. 
 
Abstract word count: 243 
 
Key words: sleep apnea, overweight, hypoxia 
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INTRODUCTION 
 
Obesity is one of the most important risk factors for sleep-disordered breathing (SDB) 
(1). Epidemiological studies have shown that the prevalence of SDB is strongly 
associated with excess body weight (2), and that weight gain independently predicts the 
development of SDB (3). Moreover, most (4) but not all (5) interventional studies have 
shown that weight loss is effective in reducing apneas and hypopneas. As the 
prevalence of obesity is increasing across industrialized nations, it is predicted that this 
will cause a corresponding increase in the prevalence of SDB (1,6). 
 
The frequency of apneas and hypopneas increases with obesity (3,7). Moreover, the 
frequency of breathing events is an important predictor of the consequences of SDB, 
with a longitudinal dose-response relationship between the apnea-hypopnea index (AHI) 
and the prevalence of cardiovascular morbidity (8). The severity of oxygen desaturation 
during obstructive breathing events, and the cumulative burden of nocturnal hypoxia are 
important factors in this relationship; they also predict cardiovascular morbidity in SDB 
patients, independent of the frequency of breathing events (9,10). Since excess body 
weight is known to predispose to more severe oxygen desaturation during voluntary 
apneas (11), obese patients with SDB may be disadvantaged by greater oxygen 
desaturation during apneas and hypopneas, as well as an increased event frequency.  
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The primary aim of the present study was to measure the impact of obesity on oxygen 
desaturation, independent of confounding factors, in a large population of 30-62 year-old 
community-dwelling men and women studied as part of the Wisconsin Sleep Cohort 
Study. Multiple regression analysis of over 37,000 breathing events was used to develop 
a predictive model to test the hypothesis that obesity was associated with greater 
oxygen desaturation during apneas and hypopneas independent of confounding 
variables and covariates.  
 
METHODS 
 
Participants 
Participants were 750 adults from the Wisconsin Sleep Cohort Study (3) (described in 
the online supplement), an ongoing epidemiologic investigation of the natural history of 
SDB. The study was approved by the University of Wisconsin Health Sciences 
Institutional Review Board. Participants gave written informed consent. 
 
Measurements 
Body habitus measures, including height (m), weight (kg), waist, neck and hip 
circumference (cm) were measured using standard procedures (12). Body mass index 
(BMI) was calculated (kg/m2). Data on medical history, medication use, smoking habits 
and alcohol consumption were obtained by questionnaires. Participants underwent 
attended polysomnography (Polygraph model 78, Grass Instruments, Quincy, MA). 
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Measurements (described in detail in the online supplement) included 
electroencephalography, electrooculography, chin electromyography, blood oxygen 
saturation, oral and nasal airflow, thoracic and abdominal excursions, and body position. 
 
Sleep scoring was performed using conventional criteria (13). Respiratory signals were 
analyzed with an automated Sleep Analysis Program (SAP). This software program, 
developed for the Wisconsin Sleep Cohort Study and designed for the detection and 
characterization of hypopnea and apnea events of SDB, was previously described and 
validated (14) and is also described in the online supplement. All breathing events that 
produced an oxygen desaturation ≥2% were analyzed. The following parameters were 
recorded for each event: oxygen saturation at the start of the event (baseline SaO2), 
end-event SaO2, ∆SaO2 (end-event minus initial SaO2), relative change in tidal volume 
during an event (∆VT), event duration (scored from the VT signal), body position, sleep 
state (rapid eye movement [REM] or non-REM [NREM] sleep), and time of event (time 
since first event). Hypopneas were defined as reduction in VT≥20%, and apneas as 
cessation of breathing for ≥10 seconds. The AHI was calculated as the mean number of 
apneas and hypopneas associated with ∆SaO2≥2%, per hour of sleep (AHI2%). 
Additional models that included only events associated with ∆SaO2≥3%, were also 
examined. 
 
Statistical Analysis 
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Mixed-effects linear regression models were used to examine the effect of excess body 
weight on ∆SaO2 during breathing events, after accounting for covariates. The primary 
predictor variable was BMI. Alternative body habitus measures such as neck and waist 
circumferences were also examined. Additional variables examined as covariates or 
interacting variables included: age, gender, ∆VT, time of event, sleep state, body position 
in which event occurred, baseline SaO2, event duration, FEV1, FVC, FEV1 %predicted,  
cigarette smoking, and alcohol consumption. 
 
Using SAS PROC MIXED (SAS Institute Inc, Cary, NC), ∆SaO2 was regressed on the 
predictor variables which were modeled as random (intercept and baseline SaO2) or 
fixed (all other predictors) effects; interactions among predictor variables were also 
evaluated. Statistically significant (2-sided p-value<0.05) covariates, interactions and 
quadratic terms were retained in presented models.  
 
The primary model examined breathing events that produced ≥2% ∆SaO2. Because 
most subjects had multiple breathing events,  a within-subject correlation structure was 
fitted in the models. The best-fitting correlation structure (assessed by likelihood ratio 
tests and the Bayesian Information Criterion) was a “spatial” covariance matrix (spatial 
exponential anisotropic) with time of event (unequally-spaced, within-subject) as the 
single “spatial” dimension (15).  
 
RESULTS 
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1463 participants had technically adequate baseline polysomnography sleep studies. 
675 of these were not suitable for SAP analyses as the sleep studies were performed 
after the Wisconsin Sleep Cohort migrated to an alternative software platform that was 
not compatible with SAP analysis. Of the 788 remaining SAP-analyzable studies, 17 of 
these were excluded due to participant-reported physician-diagnosed heart attack, heart 
failure, stroke or emphysema; 21 were excluded due to the use of sleep apnea 
treatment (continuous positive airway pressure) at the time of sleep study. 
 
Demographic and anthropometric details of the 750 participants are presented in Table 
1 (and Tables E1-E5 on-line supplement). Mean age of participants was 45 years and 
56% were male. Mean(SD) BMI was 29(6) kg/m2 and mean(SD) AHI2% was 9.5(12.0).  
 
The 750 participants had a mean(SD) sleep time of 6.0(1.1) hours, and a total of 37,473 
breathing events. Table 2 shows the number of breathing events by BMI categories. 
Obese participants (BMI≥30 kg/m2) comprised 40% of the cohort, but contributed 62% of 
breathing events.  
 
Table 3 shows descriptive data for all breathing events. The mean(SD) oxygen 
desaturation (∆SaO2) was 4.8(3.1)%. Due to the right-skewed distribution of ∆SaO2, the 
majority of events were associated with a ∆SaO2<4% (median ∆SaO2=3.7%, range 2–
24%). Most breathing events were hypopneas (92%) and a disproportionate number of 
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breathing events occurred in REM sleep: mean REM sleep time was 18% of total sleep 
time but encompassed 26% of all breathing events.  
 
Regression Analysis 
The regression model (Table 4) fitted a significant linear relationship between BMI and 
∆SaO2, independent of age, gender, sleeping position, baseline SaO2 and event 
duration. For example, the model presented in Table 4 predicts that 50 year old non-
smoking males with a BMI of 30kg/m2 and a baseline SaO2 of 100%, who experience a 
30 second hypopnea with an 80% ∆VT while on their side in NREM sleep, would be 
expected to have a mean ∆SaO2 of 5.9% (95% CI: 5.5 to 6.2%). The primary variable of 
interest in this study is BMI, with a regression coefficient of 0.055 (SE, 0.014). This 
indicates that for each increment in BMI of 1 kg/m2, a mean 0.055% greater ∆SaO2 is 
expected. Thus, in the example, if BMI was 40kg/m2 rather than 30kg/m2, with all other 
variables unchanged, we predict an average 0.55% greater desaturation (i.e., total 
∆SaO2 of 6.4%). In addition, the model also showed statistically significant interactions 
between BMI and sleep state as well as BMI and ∆VT, indicating that: 1) the effect of 
BMI on ∆SaO2 was considerably greater during REM sleep; and, 2) the impact of ∆VT on 
∆SaO2 increased with increasing BMI (see the 3rd footnote [‡] to Table 4). Thus, for 
example, for hypopneas occurring during REM sleep, the coefficient would be 0.097 
(=0.055 + 0.042) and we predict an additional desaturation of ~1.0% for each 10kg/m2 
increment in BMI (e.g., a total estimated mean ∆SaO2=6.9% for the 40kg/m2 vs. 30kg/m2 
example above). No other examined variables (age, gender, etc.) were found to 
significantly interact with BMI. The interaction of sleep state and BMI from the regression 
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model is depicted in Figure 1A for men and 1B for women. The additional model that 
included only events associated with ∆SaO2≥3%, yielded very similar results to those 
presented in Table 4. In the ∆SaO2≥3% model the analogous coefficient for BMI in Table 
4 (i.e., 0.055; SE=0.014) was 0.052 (SE=0.015). 
 
The regression model also revealed the importance of other variables (in addition to 
BMI) in determining the ∆SaO2 (Table 4). The supine position was associated with 
increased desaturation, predicting an estimated 0.54% greater ∆SaO2 compared to that 
expected during similar events occurring in the prone or lateral position (Figure 2). As 
expected, longer event duration and greater ∆VT produced greater ∆SaO2. Accounting 
for event-level characteristics, increasing age and smoking also independently predicted 
greater oxygen desaturation. Men were estimated to have an average 0.26% 
(SE=0.08%) greater ∆SaO2 than women. That is, if a hypopnea with a given set of 
characteristics (duration, ∆VT, etc.) was expected to produce a 5.00% ∆SaO2 in a man, 
then a similar hypopnea in a woman would be expected to produce a 4.74% ∆SaO2.  
 
Eight percent of all events were identified by SAP as apneas. Due to the relatively few 
apnea events, we had insufficient power to perform apnea-only modeling. However, in 
the regression analysis of all respiratory events (Table 4) an indicator variable for apnea 
was significant (coefficient=0.25; SE=0.07), indicating that apneas produced greater 
oxygen desaturation than might be expected from extrapolating hypopnea events to 
∆VT=100%. 
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In addition to BMI, we also examined other measures of body habitus in relation to 
oxygen desaturation including neck and waist girth and the waist:hip ratio. None were 
substantially better predictors of ∆SaO2 than BMI. However, we have included 
regression model results in the online data supplement (Table E7) that describe the 
estimated gender-specific associations of BMI, neck girth, waist girth and waist:hip ratio 
with ∆SaO2. We also examined the addition of spirometric measures of lung function, 
including FEV1% predicted and FEV1/FVC to the presented models. In this population of 
healthy working adults, these variables had no appreciable effect on the other predictor 
variable coefficients, nor were they statistically significant predictors of ∆SaO2 
independent of the other variables in the model.  
 
 
DISCUSSION 
 
The findings of this study show that BMI is an important predictor of oxygen desaturation 
during SDB. The regression model estimated a linear relationship between BMI and 
∆SaO2, independent of age, gender, sleeping position, baseline SaO2 and event 
duration. The model also showed two interactions. First, the impact of BMI is 
significantly modified by sleep state; thus, ∆SaO2 during apnea or hypopnea is predicted 
to be greater in REM compared to NREM sleep, but especially so in persons with higher 
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BMI. Secondly, during hypopnea, the (expected) positive association between ∆VT and 
∆SaO2 is most marked in obese individuals. 
 
Our model also showed that additional variables were significant predictors of the 
severity of the oxygen desaturation. Supine sleeping position was an independent 
predictor of greater oxygen desaturation, compared to the lateral or prone position. The 
SaO2 at the start of the breathing event (baseline SaO2), and the reduction in tidal 
volume occurring during hypopnea, were also predictors of oxygen desaturation.  
 
Previous studies evaluating the effect of obesity on oxygen desaturation during SDB 
have not to systematically examined or accounted for potential interacting or 
confounding (16,17). In the present study we found that body habitus predicts oxygen 
desaturation severity during apneic and hypopneic events independent of individual- and 
event-level characteristics. Sleeping position (18), sleep state (19), duration of breathing 
event (20), gender (21) and baseline oxygen saturation (22) have all been previously 
reported to influence the severity of oxygen desaturation during an apneic / hypopneic 
event. Our model has also shown that these variables are significant independent 
predictors of the severity of oxygen desaturation; thus, for instance, supine sleeping 
position predicted greater oxygen desaturation during breathing events, compared to the 
lateral or prone position. Moreover, our model demonstrates that male gender, 
increasing age and smoking are also significant independent predictors of ∆SaO2. 
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Mechanisms by which obesity increases ∆SaO2 during apnea and hypopnea 
 
The rate of desaturation during apnea is influenced by many physiological variables, 
including alveolar volume (23). The reservoir of oxygen in the lung is proportional to the 
alveolar volume, as shown in healthy individuals who experience significantly greater 
∆SaO2 following voluntary apnea at residual volume, compared to voluntary apnea at 
total lung capacity (24). The effect of excess body weight on lung volume, is the 
principal mechanism by which BMI influences ΔSaO2 (23), an effect likely accentuated in 
the presence of greater whole-body oxygen demand. Excess body weight causes 
significant reduction in all lung volumes, with the greatest reduction in functional residual 
capacity (FRC) and expiratory reserve volume (ERV) even in mildly obese and 
overweight individuals (24-26). In morbid obesity, FRC may even approach residual 
volume (24). In SDB, ERV has been shown to be strongly correlated with the severity of 
apnea-induced desaturation (27) and mean nocturnal oxygen saturation (17,28). 
Moreover, weight loss has been shown to result in improvements in overnight oxygen 
saturation in parallel with increase in the FRC and ERV (29).  
 
In addition to reducing the reserve of oxygen in the lung, excess body weight also 
impacts the ventilation-perfusion ratio, another important determinant of ΔSaO2 (23). In 
obesity, the combined effect of a reduction in FRC and increase in closing volume (30) 
results in a greater propensity for small airway closure, causing ventilation perfusion 
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mismatching and pulmonary shunting, thereby exacerbating oxygen desaturation (31-
33).  
 
The effect of obesity on lung volume and rate of oxygen consumption may also explain 
the significant interaction between BMI and sleep state predicted by our model. During 
REM sleep, further increase in upper airway resistance (34) may increase the work of 
breathing, while reduction in lung volumes and ventilation perfusion mismatching (35) 
will increase the rate of oxygen desaturation. Moreover, chest wall excursion is reduced 
during the atonia of REM sleep and there is a greater dependence upon the 
diaphragmatic contribution to ventilation, (36,37) which may be impinged by abdominal 
adiposity.  
 
Reduction in lung volume could also explain the greater oxygen desaturation observed 
to occur in the supine sleeping position. Compared to the sitting and lateral decubitus 
position, supine posture causes a significant reduction in FRC and ERV, in healthy 
individuals (38,39).   
 
Our primary measure of body habitus, the BMI, does not characterize the peripheral and 
central distribution of excess body fat (40). Thus, we also examined alternative 
measures of body habitus. Waist girth might be expected to show similar, if not stronger, 
associations with ΔSaO2 as BMI since central adiposity may have greater impact on 
lung function due to diaphragmatic displacement and thoracic wall impingement by 
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visceral and chest wall fat. Although BMI is highly correlated with end expiratory lung 
volume (41), a recent study has reported that waist girth is strongly associated with 
impaired lung function independent of BMI (42). In our sample, the sex- and age-
adjusted correlation of BMI and waist girth was 0.90, and only BMI was a significant 
predictor of ΔSaO2 when both measures were included in our model simultaneously. 
Thus, BMI and waist girth might be viewed as essentially interchangeable in our data. 
We chose to focus our results on BMI as this is the most commonly used metric of 
excess body weight. 
 
Strengths and limitations 
 
A strength of our study is the use of data from a large community-based sample. Over 
37,000 breathing events were detected in participants with a wide spectrum of body 
habitus and severity of SDB, allowing examination of the independent impact of 
individual variables and interaction between variables. Previous studies investigating the 
impact of obesity on ∆SaO2 have only evaluated selected populations of sleep clinic 
patients (16) or patients assessed for bariatric surgery (17). As there was little racial 
diversity in our sample (94% white, see Table E4), we were not able to examine whether 
associations between obesity and ∆SaO2 varied by race. 
 
Two limitations in particular need to be considered when interpreting the findings of our 
study. First, detailed pulmonary function testing was not available in our study 
population. Excess body weight predominately results in a restrictive lung defect with 
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reduction in FRC and ERV (24) and it is possible that inclusion of these variables in our 
predictive model may have altered the measured impact of BMI on ∆SaO2. The lack of 
lung volume measurements also limits our physiological interpretation of the model; 
although we speculate that the impact of excess body weight on lung volume is the key 
mechanism by which obesity causes greater ∆SaO2, we can not rule out other factors. 
For instance, right to left cardiac shunting causes increased oxygen desaturation (43) 
and recent reports have identified a higher prevalence of patent foramen ovale in sleep 
apnea patients compared to persons without sleep apnea (44,45). Although we can not 
exclude unidentified patent foramen ovale causing greater ∆SaO2 in our study 
population, we are not aware of any data to suggest that patent foramen ovale becomes 
more prevalent as BMI increases. Second, although the SAP uses calibrated respiratory 
inductance plethysmography for measurement of respiratory events, the calibration may 
become unreliable following a change in sleeping position (46). However, as the SAP 
measures relative differences in tidal volume based on the preceding breaths, this 
limitation is unlikely to have strongly influenced our results. 
 
The present study concentrated on oxygen desaturation during discrete apnea and 
hypopnea breathing events, but obese individuals are also at risk of nocturnal 
hypoventilation and hypercapnia. This issue could not be evaluated in our model but 
may also be important in view of the association of the obesity hypoventilation syndrome 
with increased mortality and morbidity (47). 
 
Clinical Implications 
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Our predictive model provides clinically important information to show that obese 
individuals are exposed to a greater burden of oxygen desaturation during sleep-
disordered breathing. While this analysis does not confirm the long term adverse 
consequences of greater oxygen desaturation in obese individuals, the detrimental 
effects of intermittent hypoxia are well described (48), and there is evidence to show that 
the severity of intermittent hypoxia is important in the pathophysiologic consequences of 
SDB. For example, hypopneas associated with a 4% or greater ∆SaO2 are a better 
predictor of prevalent cardiovascular disease compared to events associated with a 3% 
or less ∆SaO2 (10); and, in a recent, novel experimental model of intermittent hypoxia in 
humans, healthy adults exposed to intermittent hypoxia during sleep over a 2-week 
period developed a significant increase in waking mean arterial blood pressure of 5 
mmHg (49). 
 
Summary 
 
The body mass index is an important predictor of the severity of oxygen desaturation 
during apneic and hypopneic events of sleep-disordered breathing, independent of age, 
gender, sleeping position, smoking history, baseline SaO2 and event duration. The 
association of BMI on oxygen desaturation is particularly strong in REM sleep. Excess 
body weight has been widely demonstrated to be strongly associated with a greater risk 
of having SDB and increased number of breathing events among persons with SDB. For 
the first time, we have comprehensively quantified the additional burden that excess 
body weight has on the severity of individual breathing events. These findings contribute 
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to a fuller understanding of the impact of excess body weight on SDB.
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TABLES  
 
Table 1. Descriptive characteristics of 750 participants included in Sleep Analysis 
Program (SAP) analysis 
 
Variable        Mean (SD)   Range  
Age (years)       45 (7)     30 – 62 
Body mass index (kg/m2)   29 (6)     18 – 62 
Neck circumference (cm)   38 (4)     27 – 53 
Waist:hip ratio (men)    0.95 (0.06)   0.79 – 1.24 
Waist:hip ratio (women)   0.82 (0.07)   0.34 – 1.08 
AHI2%, SAP-scored (events/hr)   9.5 (12.0)    0.3 – 91 
AHI4%, SAP-scored (events/hr)   4.5 (8.7)    0.1 – 79 
FEV1, % predicted      107 (16)    43-153 
FEV1/FVC       0.82 (0.07)   0.36-1.0 
Epworth Sleepiness Scale   8.4 (4.3)    0 – 22 
Current smoker N (%)    148 (20%)  
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Table 2. Distribution of Participants (N=750) and Breathing Events (N=37,473) by 
Body Mass Index (BMI) category 
 
BMI Category  
  (kg/m2)    <25   25-29.9  30-34.9  35-39.9  ≥40   
Participants  
N (%)    199 (27)  257 (34)  184 (25)  57 (8)   53 (7)  
Breathing events  
N (%)    3,889 (10) 10,380 (28) 13,210 (35) 5,013 (13) 4,981 (13) 
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Table 3. Descriptive Data for SAP Analyzed  Breathing Events (n=37,473) 
 
Variable        Mean (SD)  Median  Range  
∆SaO2 (%)       4.8 (3.1)   3.7    2.0 – 24.0 
SaO2 at start of event (%)   95 (3)    95    79 – 100 
SaO2 at end of event (%)   90 (4)    91    75 – 98 
∆VT (%)        74 (21)   77    20 – 100 
Event duration (s)     29 (13)   26    10 – 90 
 
  
Table 4. ∆SaO2 prediction model and the impact of changing individual variables on an event with a predicted 
∆SaO2 of 5.9% 
             Baseline   Comparison   Expected difference Expected new 
Variable*    Coefficient† (SE)  Value     value     in ∆SaO2, %    ∆SaO2, %  
BMI ‡     0.055 (0.014)   30 kg/m2    40 kg/m2    +0.55      6.4 
Sleep state ‡   0.39 (0.05)    NREM sleep  REM sleep   +0.39      6.3 
∆VT ‡     0.030 (0.002)                       
 (∆VT)2       0.00054 (0.00005)  80%     90%     +0.35      6.2  
Baseline SaO2   0.52 (0.04)     
  (baseline SaO2)2 0.025 (0.003)   100%    98% §     -0.93      4.9 
Event type   0.25 (0.07)    Hypopnea  Apnea ║    +0.25      6.1 
Body position  0.54 (0.07)    Lateral   Back     +0.54      6.4 
Event duration  0.025 (0.002)                       
 (event duration)2 0.00016 (0.00005)  30 sec   60 sec     +0.88      6.8 
Time of event  -0.022 (0.011)   1st event   1 hr after 1st event -0.02      5.9 
Gender    -0.26 (0.08)    Male    Female    -0.26      5.6 
Age     0.028 (0.006)   50 yrs    60 yrs     +0.28      6.2 
Smoking    0.20 (0.07)    Non-smoking  1 pack/day   +0.20      6.1 
 1
* To aid interpretation of the model intercept (5.88, SE=0.17), select variables (BMI, ∆VT, Baseline Sa02, event duration, 
and age) were “centered” in fitting the model by subtracting constants from their observed values as indicated by the 
“Starting value” column: i.e., BMI was centered at 30kg/m2 (“BMI”=BMI-30); ∆VT at 80% (“∆VT”=∆VT -80%); etc.  
 
† All coefficients (including quadratic and interaction terms) are significantly different from 0 with a p<0.001 except for 
smoking (p=0.008) and time of event (p=0.04). 
 
‡ There were also significant interactions of BMI*sleep state (interaction coefficient=0.042, SE=0.009) and BMI*∆VT 
(interaction coefficient=0.00082, SE=0.00018), indicating that the association of BMI and ∆SaO2 is both stronger in REM 
compared to NREM sleep, and that the effect of ∆VT on ∆SaO2 increases with increasing BMI. 
 
§ The fitted quadratic relationship between Baseline Sa02 and ∆SaO2 suggested that baseline Sa02<80% was strongly 
associated with greater ∆SaO2 reductions, but also that there are modest decreased expected reductions in ∆SaO2 with 
increasing baseline SaO2 for baseline SaO2>80%.  
 
║ Note that comparing a hypopnea with ∆VT=80% to Apnea with ∆VT=100% would yield an expected 1.1% greater ∆SaO2 
(i.e., 5.9+1.1=7.0% “expected new ∆SaO2”). 
  
FIGURES 
 
Figure Legends 
 
Figure 1. Predicted ΔSaO2 for a hypopnea (100% baseline SaO2, 30 seconds in 
duration, with an 80% ΔVT, in supine 50-year olds) by BMI and sleep state in men 
(Figure 1A) and women (Figure 1B). Error bars indicate upper (REM) and lower (NREM) 
95% confidence limit for predicted mean ΔSaO2. 
 
Figure 2. Predicted ΔSaO2 for a hypopnea (100% baseline SaO2, 30 seconds in 
duration, with an 80% ΔVT during REM sleep, in supine 50-year olds) by BMI and 
sleeping position in women. Error bars indicate upper (Supine) and lower (Side) 95% 
confidence limit for predicted mean ΔSaO2. 
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FIGURE 2. 
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ONLINE SUPPLEMENT 
 
SUPPLEMENTAL METHODS 
 
Details of the Wisconsin Sleep Cohort Study 
A random selection of men and women, ages 30-60, was recruited from a sampling 
frame of payroll records of 4 Wisconsin state agencies for a survey of sleep 
characteristics and other factors. Of 2940 survey participants invited to participate in the 
overnight polysomnography protocol, 1546 agreed (53%; the primary reported reason 
for non-participation was the burden of sleeping overnight in a sleep laboratory). These 
1546 comprise the Wisconsin Sleep Cohort sample and had baseline polysomnography 
studies between 1989 and 2000. Of the 1546 participants, 1463 had useable sleep 
studies (high quality data from all required polysomnography channels and at least 3 
hours of objectively measured sleep in the laboratory). Of these 1463 participants with 
useable sleep studies, 788 participants had polysomnography studies that were suitable 
for SAP analysis. 675 participants were excluded from SAP analyses as their sleep 
studies were performed after the Wisconsin Sleep Cohort migrated to an alternative 
software platform that was unsuitable for SAP analyses (the majority of cases), or there 
were missing key electronic data channels e.g. the oxygen saturation channel was 
recorded only to paper records for early studies, or there was electronic storage failure. 
Of the 788 participants that had SAP-analyzable studies, 21 were excluded from this 
report due to the use of sleep apnea treatment (continuous positive airway pressure) at 
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the time of sleep study, and 17 were excluded for self-reported history of severe 
physician-diagnosed cardiovascular or pulmonary medical conditions: 9 for myocardial 
infarction, 2 for congestive heart failure, 3 for stroke, and 3 for emphysema. Key 
Demographic and co morbidity details are given in Table E1 to E5  
 
Body habitus assessment, medical history and covariates 
Body habitus measures, including height, weight, body mass index, waist, neck and hip 
girths and skin fold thickness (4 sites—subscapular, suprailiac, triceps, biceps) were 
measured using standard procedures (E1). Data on medical history (including diabetes, 
cardiovascular disease, stroke, and hypertension), medication use, smoking habits 
(current and past cigarette packs per week), age, and other factors were obtained by 
interview and questionnaires. Spirometic variables including FEV1 and FVC were 
assessed by a water-sealed spirometer using American Thoracic Society standards 
prevailing at the time of data collection. 
 
Polysomnography 
After the assessment body habitus, technicians affixed polysomnography leads to each 
participant and performed calibrations. An 18-channel polysomnographic recording 
system (model 78, Grass Instruments, Quincy, Mass.) was used to assess sleep state 
and respiratory and body position variables. Sleep state was measured with 
electroencephalography, electrooculography, and chin electromyography. These signals 
were used to determine the sleep stage for each 30-second interval of the 
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polysomnographic record, according to conventional criteria (E2). Arterial oxygen 
saturation, oral and nasal airflow, nasal air pressure, and rib-cage and abdominal 
respiratory motion were used to assess episodes of sleep-disordered breathing. Oxygen 
saturation was continuously recorded with a pulse oximeter (Ohmeda 3740, Englewood, 
CO). Stalk-mounted thermocouples (ProTec, Hendersonville, Tenn.) detected oral and 
nasal airflow. A pressure transducer (Validyne Engineering, Northridge,CA) measured 
air pressure at the nares. Respiratory inductance plethysmography (Respitrace, 
Ambulatory Monitoring, Ardsley, N.Y.) recorded rib-cage and abdominal excursions. 
Body position monitoring (mercury switch, Vitalog) was supplemented by sleep 
technician observations and notations of body position change.  
 
Description of Sleep Analysis Program (SAP)  
A detailed description and validation of SAP is given by Taha et al (E3). The SAP initially 
identifies a desaturation and then determines if an apnea or hypopnea is responsible for 
the desaturation. The algorithm analyzes the digitized SaO2 signal, averaged every 0.5 
second, and detects a desaturation if the following conditions are identified; the SaO2 
falls at a rate greater than 0.1% per second but less than 4% per second, there is a 
minimum ∆SaO2 of at least 2%, and the SaO2 returns to a level either 1% below starting 
saturation or 3% above the nadir saturation. The total time from start to finish must be 
≥10 and ≤60 seconds. These levels are defined to avoid false detection of artifactual 
fluctuations in the SaO2 signal. 
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Breath detection 
A breath was defined from the digitized sum respiratory inductance plethysmography 
(RIP) signal as the period from the start of one inspiration to the start of the next 
inspiration. The RIP signal was calibrated by first having subjects perform an isovolume 
maneuver while adjusting the relative gains of the abdomen and rib cage component 
signals such that a net zero sum signal was obtained. Following this adjustment the 
subject was instructed to breathe through a spirometer at increasing tidal volumes. The 
sum signal was then calibrated against the spirometer readings using a linear regression 
equation. For each detected breath, the following parameters were computed: 
inspiratory time (TI), expiratory time (TE), breathing frequency per minute (fb), tidal 
volume (VT = average of inspiratory and expiratory volumes), inspiratory duty cycle [T/(TI 
+ TE)], and minute ventilation (VE = VT X fb).  
 
Apnea and hypopnea 
An apnea is defined as a period of no inspiration lasting 10-60 seconds, as indicated by 
the differentiated sum RIP signal. A hypopnea is identified by the algorithm when three 
or more breaths have a fall in magnitude of ≥20% of the (baseline) breath immediately 
preceding the onset of hypopnea, followed by a breath returning to  ≥90% of the 
baseline breath within 180 seconds. This analysis did not use SAP to distinguish 
obstructive, mixed or central apneas since SAP vs. manually-scored sleep studies 
showed limited correspondence (71% agreement) when scoring apnea subtype (E3). 
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Validation of SAP 
Taha et al. compared the automated scoring algorithm with manual scoring of 
respiratory events and showed that SAP detected 93.1% of all manually scored apneas 
and hypopnoeas, with a positive predictive value of 96.9% (E3).  
 
Apnea-hypopnea index measurement 
For the primary analysis, only apneas and hyponeas associated with an blood oxygen 
desaturation ≥2% were included in the AHI2%. In keeping with common clinical 
thresholds, the AHI4% was also determined by analysis of breathing events associated 
with ≥4% oxygen desaturation. 
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SUPPLEMENTAL RESULTS 
 
Additional demographic and anthropometric details are presented in Tables E1-E5. 
Table E1 compares subjects included in this analysis with all 1493 subjects with 
baseline polysomnography studies with the 750 participants used for this study. 
Because the majority of the excluded subjects had baseline studies that occurred after 
1995 (all included subjects had baseline studies prior to 1995), the excluded Wisconsin 
Sleep Cohort participants tended to be older, heavier and with higher mean AHI at the 
time of their studies compared to the 750 participants included in this analysis. Table E2 
presents the prevalence of selected comorbid conditions in the sample. Table E3 breaks 
down the racial/ethnic composition of participants. Self-reported snoring category 
prevalences are given in Table E4. Table E5 presents use of caffeinated beverages in 
the sample. 
 
The Wisconsin Sleep Cohort typically uses technician-scored apnea-hypopnea indices 
in which hypopneas are required to have ≥4% ∆SaO2 (“AHI4%”). In this sample the mean 
(SD) technician-scored AHI4%, tech-scored was 4.6 (9.8) events/hr vs. the SAP-scored 
AHI4%, SAP-scored which was 4.5 (8.7) events/hr (p-value for difference by paired t-
test=0.35, correlation of AHI4%, tech-scored and AHI4%, SAP-scored=0.94). Table E6 shows the 
SAP-scored and technician-scored events. 
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Table E7 summarizes the results of models similar to those presented in Table 4 except 
that: 1) neck girth, waist girth and waist:hip ratio were substituted for BMI so that readers 
interested in those measures could compare them to the BMI-specific results; and, 2) 
gender-specific results are given in addition to models that included both men and 
women. The models were otherwise analogous to that presented in Table 4: ∆SaO2 was 
regressed on the indicated body habitus variable, gender (except in gender-specific 
models), age, current smoking indicator, sleep state indicator (REM, NREM), ∆VT, 
(∆VT)2, baseline SaO2, (baseline SaO2)2, event type indicator (apnea or hypopnea), body 
position indicator (supine or other), event duration, (event duration)2, time of event, and 
interaction terms for body habitus variable–∆VT and body habitus variable–event 
duration. There were no significant differences between body habitus coefficients 
estimated for men and women. That is, in models (not shown) using all subjects, p-
values for gender–body habitus interaction terms were all >0.22, indicating no evidence 
for different associations between body habitus and ∆SaO2 between men and women. 
However, gender was a significant main effect (p<0.001) in all such models (men tended 
to have greater ∆SaO2 holding all other predictor variables constant). 
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ONLINE SUPPLEMENT TABLES 
 
Table E1. Key Demographic and Anthropometric Measurements for Wisconsin 
Sleep Cohort Participants Included and Excluded from SAP analysis* 
 
         Participants with SAP-   All participants with 
 Characteristic     scoreable sleep studies    valid sleep studies 
N         750         1463 
Male (%)       55          53 
Age (years)      45          47 
BMI (kg/m2)      29          30 
AHI4%, technician-scored     4.6          5.2 
(events/hr)       
 
*Data presented as mean values, except where otherwise stated. 
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Table E2. Self-reported physician-diagnosed comorbidity (N=750*) 
 
Co-morbidity   N   %     
Atherosclerosis   4   0.5% 
Arrhythmia    78   11% 
Angina     3   0.4% 
Hypertension    117  16% 
Diabetes      17   2.3% 
Asthma     77   10% 
* Note that 17 subjects who reported previous physician-diagnosed heart attack or heart 
failure were excluded from the analyses. 
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Table E3. Race/ethnicity  of participants (N=750) 
 
Race/ethnicity   N   %    
American Indian            6          0.8% 
Asian                11         1.5%  
Black                 9          1.2%  
Hispanic               6          0.8%  
White                702        94% 
Other                  5          0.7%  
Missing     11   1.5% 
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Table E4. Self reported snoring (N=750) 
 
Snoring category                N   %    
Never                    134  18% 
Rarely - only once or a few times ever.           68   9.1% 
Sometimes - a few nights per month; under special circumstances.   122  16% 
At least once a week, but pattern may be irregular.       25   3.3% 
Several nights (3 to 5) per week.             88   12% 
Every night or almost every night.            254  34% 
Do not know.                  44   5.9% 
Missing                   15   2.0% 
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Table E5. Typical caffeine consumption (N=750)* 
 
Variable          Mean (SD)   Range 
Caffeinated soda (12 oz. cans/day)  0.9 (1.3)   0 - 10 
Caffeinated coffee (cups/day)    2.7 (2.9)   0 - 20 
*5 subjects reported use of caffeine-containing supplements (e.g. No-Doze) 
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Table E6. SAP and technician scored AHI at varying desaturation thresholds 
(N=750). 
Variable        Mean   Median  Range   
AHI2%, SAP-scored (events/hr)   9.5    5.0    0.3 - 91 
AHI4%, SAP-scored (events/hr)   4.5    1.3    0.1 - 79 
AHI4%, tech-scored (events/hr)   4.6    1.2    0.0 – 82 
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Table E7: Summary of 12 mixed-effects linear regression models* with body habitus 
variables predicting ∆SaO2 for all subjects, as well as men and women separately.  
 
Regression model body habitus           p-value for body  
predictor variables—for all    body habitus variable   habitus interaction with: 
participants and by gender   coefficient (SE), p-value  ∆VT   sleep state 
  
BMI, 10 kg/m2 increment 
(centered at BMI=30 kg/m2)  
            
All (N=750)      0.55 (0.14), p<0.001   <0.001  <0.001 
  
Men (N=414)      0.62 (0.20), p=0.002   0.01   <0.001 
 
Women (N=336)     0.52 (0.20), p=0.009   <0.001  0.002  
 
 
Neck girth, 5 cm increment        
(centered at neck girth=38 cm)  
            
 All (N=750)      0.49 (0.09), p<0.001   <0.001  0.003  
  
Men (N=414)      0.53 (0.14), p<0.001   0.001   0.004   
 
Women (N=336)     0.37 (0.11), p=0.001   <0.001  0.014  
 
 
Waist girth, 10 cm increment       
(centered at waist girth=95 cm)             
 
All (N=750)      0.22 (0.05), p<0.001   <0.001  0.001  
  
Men (N=414)      0.27 (0.08), p<0.001   0.002   0.003  
 
Women (N=336)     0.17 (0.05), p=0.001   <0.001  0.047 
 
 
Waist/hip ratio, 0.1 unit increment       
(centered at waist/hip ratio=0.90) 
             
 All (N=750)      0.24 (0.08), p=0.003   0.001   0.43 
  
Men (N=414)      0.25 (0.14), p=0.066   0.028   0.087 
 
Women (N=336)     0.21 (0.10), p=0.030   0.12   0.65 
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*∆SaO2 was regressed on the indicated body habitus variable, gender, age, current 
smoking indicator, sleep state indicator (REM, NREM), ∆VT, (∆VT)2, baseline SaO2, 
(baseline SaO2)2, event type indicator (apnea or hypopnea), body position indicator 
(supine or other), event duration, (event duration)2, time of event, and interaction terms 
for body habitus variable–∆VT and body habitus variable–event duration. The intercept 
and baseline SaO2 were modeled as random effects, all other variables as fixed effects. 
Intrasubject correlation in ∆SaO2 was modeled as a 1-dimentional (time of event) spatial 
anisotropic exponential correlation structure. 
 
